The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Magellan Health Inc

Nasdaq: MGLN
Last

(U.S.) $57.85

Today's change0.00 0.00%
Updated August 23 4:00 PM EDT. Delayed by at least 15 minutes.
 

Magellan Health Inc

Nasdaq: MGLN
Last

(U.S.) $57.85

Today's change0.00 0.00%
Updated August 23 4:00 PM EDT. Delayed by at least 15 minutes.

Magellan Health Inc closed at (U.S.)$57.85.

Although unchanged over the last five days, shares are down 6.18% for the last year to date. This security has underperformed the S&P 500 by 9.56% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $57.85
  • High--
  • Low--
  • Bid / Ask(U.S.) $28.92 / (U.S.) $86.75
  • YTD % change-6.18%
  • Volume0
  • Average volume (10-day)229,923
  • Average volume (1-month)228,387
  • Average volume (3-month)210,056
  • 52-week range(U.S.) $45.40 to (U.S.) $72.31
  • Beta0.46
  • Trailing P/E37.73×
  • P/E 1 year forward21.81×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $1.53
Updated August 23 4:00 PM EDT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2016Q1/2016Q4/2015Q3/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015
Revenue1,1641,1171,2691,190
Total other revenue--------
Total revenue1,1641,1171,2691,190
Gross profit41519313
Total cost of revenue1,1241,0661,1761,177
Total operating expense1,1491,0911,2031,204
Selling / general / administrative--------
Research & development--------
Depreciation / amortization26252827
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income152666-14
Interest income (expense), net non-operating-2-2-2-2
Gain (loss) on sale of assets--------
Other--------
Income before tax142565-15
Income after tax11325-8
Income tax, total131240-7
Net income41327-8
Total adjustments to net income--------
Net income before extra. items41327-8
Minority interest3020
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items41327-8
Inc. avail. to common incl. extra. items41327-8
Diluted net income41327-8
Dilution adjustment--------
Diluted weighted average shares24242425
Diluted EPS excluding extraordinary itemsvalue per share0.170.561.12-0.31
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.170.561.12-0.31